FDA Blasts Aveo One Last Time for 'uninterpretable' Cancer Study

Published June 12, 2013

FDA blasts Aveo one last time for 'uninterpretable' cancer study

Filed under: drug treatment programs in massachusetts

Days after the Cambridge, MA-based biotech whacked close to two-thirds of its staff as it scrambled to stay afloat in the wake of a scathing regulatory assessment of its lead drug, the developer says that the FDA has handed over the expected rejection …
Read more on FierceBiotech

Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian

Filed under: drug treatment programs in massachusetts

Chris Garabedian, the CEO of Cambridge, MA-based Sarepta Therapeutics, is one of these long-termers. He hasn't really accomplished anything of … Many smart people now believe that Sarepta has come up with the first effective drug for treating …
Read more on Xconomy

Washington IRS official who oversaw targeting is a registered Democrat

Filed under: drug treatment programs in massachusetts

Obama dismisses 'hype' over surveillance, then lauds and criticizes program [VIDEO] · Handy U-Print-It Pocket Guide: Why S.744?s a Fraud · The folly of Common Core proponents' China envy · LOOK: Amazing maps reveal how Americans say different …
Read more on Daily Caller